Across both trials, the side-effect profile matched what had been seen in prior retatrutide research, with gastrointestinal complaints chiefly diarrhea, nausea, and constipation topping the list, as is typical for GLP-1 medications, the company said
Louise Norris is an individual health insurance broker who has been writing about health insurance and health reform since 2006
Patients choose Body Balance Medical because they want real provider oversight not a one-size-fits-all subscription
Saxenda is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
In animal studies, there were concerns about adverse effects on fetal development
Most users notice visible results in 48 weeks with consistent use